Purdue Pharma L.P. Names Saeed Motahari Senior Vice President and Chief Commercial Officer

Stamford, CT – May 22, 2014 – Purdue Pharma L.P. today announced that Saeed Motahari has joined the company as Senior Vice President and Chief Commercial Officer.

“We welcome Saeed to the Purdue team. I am confident that his impressive capabilities will strengthen our organization,” said Mark Timney, President and CEO of Purdue Pharma. “Saeed’s experience and expertise make him uniquely qualified to lead our commercial efforts.”

Saeed has more than 20 years of pharmaceutical sales and marketing experience, and a proven record of achieving commercial excellence. He joins Purdue from AbbVie, where he served as Vice President of US Sales and Marketing, Specialty Brands – New Launches. In this role, he led launch preparations for AbbVie’s investigational products for HCV, Parkinson’s, and Oncology. Saeed also has a demonstrated record of building high-performing commercial teams that excel at identifying and meeting customer needs. He will bring these skills to Purdue, as well as strategy development experience, brand management success, and managed markets expertise.

“I am honored to join Purdue and am excited to help continue the company’s lengthy record of success,” said Saeed Motahari. “I look forward to working alongside the talented professionals at Purdue, as we serve our patients and customers.”

Prior to working at AbbVie, Saeed held integral roles in Sales and Marketing at Abbott Laboratories, most notably in Specialty Brands, focusing on the Renal, Endocrinology, Acute Care, and Neuroscience therapeutic areas. Before Abbott, Saeed held various commercial roles in global marketing analytics and new product development at Bristol-Myers Squibb and Hoffmann-La Roche.

About Purdue Pharma L.P.

Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on chronic pain. Headquartered in Stamford, CT, Purdue is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduepharma.com.

# # #

Contact:

Robert Josephson
Associate Director, Media Relations
(203) 588-7114
robert.josephson@pharma.com
Jim Heins
Senior Director, Public Affairs
(203) 588-8069
james.heins@pharma.com

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.